Topical apremilast cream for localized plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests a new cream form of apremilast, a medicine usually taken as a pill, for people with plaque psoriasis covering less than 10% of their body. The goal is to see if the cream is safe and effective in reducing psoriasis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic plaque psoriasis covering no more than 10% of your body surface area.
- You have not used phototherapy or systemic (pill or injection) psoriasis treatments in the last 12 weeks.
- You have not used topical (on-the-skin) psoriasis treatments in the last 4 weeks.
- You do not have significant kidney, liver, heart, blood, or mental health conditions, and are not on immunosuppressive therapy.
- You are not pregnant, breastfeeding, or planning to become pregnant within the next 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether apremilast (a pill) safely and effectively treats moderate-to-severe psoriasis. If you join, you will receive the medication and be monitored by the study team to see how well it works for you.
This study compares two oral medications, methotrexate and apremilast, to see which works better at reducing itching in people with psoriasis. You might join to help find a more effective way to relieve itch.
This study tests whether adding a special moisturizer, Ceramol PSOR cream, to standard narrowband UVB light therapy helps reduce psoriasis symptoms like itching and dryness. It is for people with mild to moderate plaque psoriasis who are already planning to have light therapy.
This study looks at how well two common plaque psoriasis medicines—deucravacitinib and apremilast—work in everyday care. It may help researchers understand which option performs better in real patients outside of a traditional drug trial.
This study tests a new prescription cream called roflumilast to see if it helps with both skin plaques and nail psoriasis. If you join, you'll apply the cream to affected areas and be monitored to see how well it works and if it's safe.
This study tests a new topical cream for treating mild to moderate plaque psoriasis. It aims to see if the cream is safe and effective for reducing psoriasis symptoms.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.